Skip to main content
. Author manuscript; available in PMC: 2021 Jul 15.
Published in final edited form as: AIDS. 2020 Jul 15;34(9):1389–1396. doi: 10.1097/QAD.0000000000002551

Table 1.

Baseline characteristics of 843 HIV-positive illicit drugs users stratified by patterns of noninjection substance use in the last 6 months.

Characteristics All 843 (100%) Crack cocaine use 659 (78%) Opioid use 157 (19%) Cocaine use 141 (17%) Methamphetamine use 138 (16%) Alcohol use 446 (53%) Cannabis use 481 (57%)
Sex (n, %) Male 566 (67%) 433 (66%) 102 (65%) 102 (72%) 104 (75%) 300 (67%) 353 (73%)
Age Median (IQR) 43 (37–48) 43 (37–48) 43 (36–48) 41 (36–47) 41 (34–48) 44 (37–49) 43 (36–48)
IDU (n, %) Yes 664 (79%) 523 (79%) 137 (87%) 113 (80%) 104 (75%) 330 (74%) 376 (78%)
Substances used Median (IQR) 2 (2–3) 3 (2–3) 4 (3–4) 4 (3–4) 3 (3–4) 3 (2–4) 3 (2–4)
Homelessness (n, %) Yes 259 (31%) 210 (32%) 52 (33%) 55 (39%) 51 (37%) 128 (29%) 154 (32%)
HIV RNA VL (log10(copies/ml)) Median (IQR) 3.1 (1.7–4.5) 3.3 (1.77–4.5) 2.7 (1.7–4.2) 3.5 (1.7–4.4) 2.3 (1.5–4.1) 2.5 (1.6–4.4) 2.7 (1.7–4.4)
CD4+ cell count (cells/(μl) Median (IQR) 340 (210–500) 335 (206–480) 330 (208–510) 352 (206–473) 430 (266–620) 345 (210–492) 362 (223–520)
ART exposure (days) Median (IQR) 180 (117–180) 180 (111–180) 180 (109–180) 180 (105–180) 180 (101–180) 180 (118–180) 180 (118–180)

ART, antiretroviral therapy.